Medication related osteonecrosis (MRONJ) in the management of CTIBL inbreast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS (Sumapaz)

Medication related osteonecrosis (MRONJ) in the management of CTIBL inbreast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS (Sumapaz)

09 ago
|
SIOMMMS Società Italiana dell’Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
|
Sumapaz

09 ago

SIOMMMS Società Italiana dell’Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro

Sumapaz

Commento dell’articolo: Ferrari S, Hars M, Biver E, Uebelhart B, Joly AC, Herrmann F, Meier C, Lippuner K. Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates....

📌 Medication related osteonecrosis (MRONJ) in the management of CTIBL inbreast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS (Sumapaz)
🏢 SIOMMMS Società Italiana dell’Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
📍 Sumapaz

Postulate a este anuncio

Muestra tus habilidades a la empresa, rellenar el formulario y deja un toque personal en la carta, ayudará el reclutador en la elección del candidato.

Suscribete a esta alerta:

Recibe por email las nuevas ofertas de trabajo para: medication related osteonecrosis (mronj) in the management of ctibl inbreast and prostate cancer patients. joint report by sipmo and siommms (sumapaz) / sumapaz

Suscribete a esta alerta:

Recibe por email las nuevas ofertas de trabajo para: medication related osteonecrosis (mronj) in the management of ctibl inbreast and prostate cancer patients. joint report by sipmo and siommms (sumapaz) / sumapaz